Table 1 Baseline characteristics blood samples

From: Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma

Blood samples

Thyroid carcinoma

(n = 14)

Multinodular goiter

(n = 14)

Healthy control

(n = 8)

p value (all groups)

Age (years)

   

0.0973

Median (IQR)

60 (52–71)

70 (55–74)

53 (48–57)

 

Sex

   

0.3241

Male % (n)

43 (6)

21 (3)

50 (4)

 

Female % (n)

57 (8)

79 (11)

50 (4)

 

Body Mass Index (kg/m2)

   

0.2916

Median (IQR)

26 (24–28)

28 (24–31)

N/A

 

Diagnosis

   

N/A

Papillary % (n)

71 (10)

N/A

N/A

 

 Microcarcinoma % (n)

7 (1)

N/A

N/A

 

Follicular % (n)

29 (4)

N/A

N/A

 

 Hürthle % (n)

21 (3)

N/A

N/A

 

Clinical response

    

Deceased within 3 years after diagnosis % (n)

14 (2)

N/A

N/A

 

Dose 131I (MBq)

(n = 9)

(n = 8)

 

**

Median (IQR)

7400 (3700–7400)

1500 (848–2446)

N/A

 
  1. Kruskal–Wallis test (two-sided) followed by Dunn’s Multiple-Comparison test or Mann–Whitney U test. Dose 131I.
  2. IQR interquartile range, MBq mega Becquerel, N/A not applicable.
  3. **p < 0.01.
Back to article page